Back
Coca-Cola FEMSA SAB de CV Vs. Travere Therapeutics, Inc. Industry Stock Comparison
Buy
60
KOF
Coca-Cola FEMSA SAB de CV
Last Price:
$95.70
Seasonality Move:
3.03%
Buy
80
TVTX
Travere Therapeutics, Inc.
Last Price:
$40.3200
Seasonality Move:
33.23%
Buy
60
Coca-Cola FEMSA SAB de CV (KOF)
is a Buy
Is Coca-Cola FEMSA SAB de CV a Buy, Sell or Hold?
-
The current Coca-Cola FEMSA SAB de CV [KOF] share price is $95.82. The Score for KOF is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
KOF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Travere Therapeutics, Inc. (TVTX)
is a Buy
Is Travere Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
-
TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KOF Stock Price Chart
What is Coca-Cola FEMSA SAB de CV's stock price today?
-
The Coca-Cola FEMSA SAB de CV share price today is $95.82Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KOF is experiencing slight selling pressure.
TVTX Stock Price Chart
What is Travere Therapeutics, Inc.'s stock price today?
-
The Travere Therapeutics, Inc. share price today is $40.2800Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.
KOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.92 | Buy |
| Relative Strength Index (14 RSI): | 67.39 | Buy |
| Chaikin Money Flow: | -4425 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (88.03 - 93.85) | Buy |
| Bollinger Bands (100): | (83.06 - 90.02) | Buy |
TVTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.67 | Buy |
| Relative Strength Index (14 RSI): | 69.35 | Buy |
| Chaikin Money Flow: | 1508490 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.0318 - 36.4718) | Buy |
| Bollinger Bands (100): | (20.7309 - 34.2909) | Buy |
KOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 94.01 | Buy |
| 20-day SMA: | 91.86 | Buy |
| 50-day SMA: | 88.89 | Buy |
| 200-day SMA: | 89.61 | Buy |
| 8-day EMA: | 94.28 | Buy |
| 20-day EMA: | 92.32 | Buy |
| 50-day EMA: | 89.73 | Buy |
| 200-day EMA: | 88.07 | Buy |
TVTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.7 | Buy |
| 20-day SMA: | 35.23 | Buy |
| 50-day SMA: | 33.43 | Buy |
| 200-day SMA: | 22.2 | Buy |
| 8-day EMA: | 28.52 | Buy |
| 20-day EMA: | 16.32 | Buy |
| 50-day EMA: | 7.67 | Buy |
| 200-day EMA: | 2.09 | Buy |
Coca-Cola FEMSA SAB de CV Earnings Growth & KOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.92 per share.
Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.
Coca-Cola FEMSA SAB de CV Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Travere Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||